Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
University of Warsaw, Warsaw, Poland.
IUBMB Life. 2020 Jun;72(6):1233-1242. doi: 10.1002/iub.2282. Epub 2020 Apr 9.
C─H⋯O hydrogen bonds constitute a unique class of cohesive interactions. Their properties are similar to those of canonical H-bonds, although their energy is significantly lower, typically in the 0.5-2.5 kcal/mol range. Polarised C─H groups, such as those adjacent to electronegative groups, or within aromatic moieties, are particularly strong donors. C─H⋯O bonds are ubiquitous in nucleic acids and in proteins, notably stabilizing the β-sheet secondary structure. They have also been observed in numerous protein-ligand interactions. Here, we analysed crystal structures, deposited in the Protein Data Bank, of complexes of FDA-approved protein kinase inhibitors with cognate kinases, to assess the possible role of C─H ⋯O hydrogen bonds. The conserved hinge motif of protein kinases with two solvent-exposed carbonyl groups and one exposed backbone amide, is well known to be involved in canonical H-bonding with inhibitors. We now find that in virtually all complexes where the inhibitor interacts with the hinge backbone, at least one of the hinge carbonyl groups accepts an H-bond from a C─H inhibitor group, which is either aromatic or adjacent to an electronegative group. These observations are important for design of hinge-binding scaffolds of novel kinase inhibitors for therapeutic use.
C─H⋯O 氢键构成了一类独特的结合相互作用。它们的性质与经典的氢键相似,尽管它们的能量显著较低,通常在 0.5-2.5 kcal/mol 范围内。带极性的 C─H 基团,如紧邻电负性基团的基团,或在芳香族部分内的基团,是特别强的供体。C─H⋯O 键在核酸和蛋白质中无处不在,特别是稳定β-折叠二级结构。它们也在许多蛋白质-配体相互作用中被观察到。在这里,我们分析了储存在蛋白质数据库中的 FDA 批准的蛋白激酶抑制剂与同源激酶复合物的晶体结构,以评估 C─H ⋯O 氢键的可能作用。蛋白激酶的保守铰链模体具有两个暴露在溶剂中的羰基和一个暴露的骨架酰胺,众所周知,它与抑制剂参与经典氢键。我们现在发现,在几乎所有抑制剂与铰链骨架相互作用的复合物中,至少有一个铰链羰基接受来自抑制剂的 C─H 基团的氢键,该基团要么是芳香族的,要么紧邻电负性基团。这些观察结果对于设计用于治疗的新型激酶抑制剂的铰链结合支架很重要。